Rigetti Computing, Inc. (RGTI)
AI stock analysis · as of Jun 15, 2026
Loading microstructure…
Rigetti Computing is a pre-commercial quantum computing pure-play building superconducting QPUs and offering quantum-computing-as-a-service. With FY2025 revenue of just ~$7M (down 34% YoY), a $216M net loss, and a ~$7B market cap (P/S ~696x), the core investment question is whether technical milestones (99.6% two-qubit fidelity, 108-qubit modular system, Quanta partnership) translate into commercial quantum advantage before dilution and cash burn impair shareholders. This is a story-stock priced on optionality, not fundamentals.
valuationExpensive on any fundamental basis — P/S ~696x and P/B ~12x against declining revenue, -57% ROE, and -$77M FCF; the price embeds optionality on quantum advantage, not current economics.
This analysis is from Jun 15, 2026. Want the latest on RGTI, plus the ability to generate fresh research on demand?
Every call we make is tracked publicly against what the stock actually did. See the track record →
One free AI report every day. No card required.
Bull case
- · Quanta Computer's $250M+ five-year commitment plus ~$35M equity purchase at $11.59 validates the roadmap and de-risks manufacturing scale-up
- · Fidelity improvements from ~98% to 99.6% (and 99.9% on prototype gates) approach the >99.9% threshold needed for quantum advantage, with modular chiplet architecture providing a credible path to 1,000+ qubits
- · C-DAC $8.4M order for a 108-qubit system (largest QPU sale to date) plus Novera commercial orders show early revenue diversification beyond pure R&D contracts
- · Diversified government funding from DARPA, DOE, AFRL, UK Innovate, India C-DAC provides non-dilutive R&D capital and geopolitical tailwinds from CHIPS Act-style initiatives
- · Short interest at 18.8% of float creates squeeze potential on positive milestone news, amplified by retail-driven quantum sector momentum
- · Strong IP moat with 121 issued patents and 160 pending, including proprietary adiabatic CZ gate scheme
Bear case
- · Valuation is extreme: P/S of ~696x and P/B of ~12x on a business with declining revenue (-34% YoY in FY2025 to $7.1M) and -3,050% net margin
- · Persistent dilution: share count grew ~17% in 2025 (283.5M to 331.3M) via ATM ($500M facility), private placements, and registered direct offerings; with only $45M cash against $77M annual FCF burn, more raises are imminent
- · B. Riley Securities issued a downgrade on 2025-11-03, signaling sell-side caution at current levels
- · Quantum advantage requires >1,000 qubits at >99.9% fidelity — management has missed prior milestones and the commercial inflection remains years away
- · Prior material weaknesses in internal controls and restated financials raise governance flags as the company loses smaller reporting company status in Q1 2026
- · A director sold 120K+ shares per recent news, and revenue is concentrated in a few government contracts subject to budget/policy risk
Catalysts
- · H2 2026 delivery of the 108-qubit C-DAC system — execution would validate scaling roadmap
- · Next earnings on 2026-05-11: watch cash runway, ATM utilization, and revenue trajectory
- · Potential short squeeze given 18.8% short float, though 1.24 days-to-cover is low (limits squeeze magnitude)
- · Further fidelity milestones approaching >99.9% on production (not prototype) chips
- · Additional government/CHIPS Act funding awards or strategic partnerships following Quanta template
- · Broader quantum-sector sentiment moves (IBM, IonQ, Google milestones) typically drag RGTI with the group
Key risks
- · Dilution overhang from $500M ATM facility plus warrants/RSUs continues to cap upside even on good news
- · Cash runway: ~$45M cash vs. ~$77M annual FCF burn implies need to raise within ~6-9 months absent new contracts
- · Technology timeline slippage — quantum advantage may take 5-10+ years, leaving years of losses to fund
- · Customer concentration in government contracts vulnerable to budget cuts or program cancellation
- · Warrant liability mark-to-market creates earnings volatility unrelated to operations
- · Sector de-rating risk if quantum hype cycle fades or a competitor (IBM, Google, IonQ) demonstrates clear lead
What to watch
- · Next earnings 2026-05-11 — cash balance, ATM drawdown pace, and FY2026 revenue guidance
- · H2 2026 C-DAC 108-qubit system delivery execution
- · Any 8-K announcing new capital raise (would confirm dilution thesis)
- · Production-chip fidelity announcements crossing 99.9% threshold
- · 52-week range $10.30-$58.15 — key technical levels at $15 (analyst low) and $30 (analyst mean)
- · Short interest changes and insider Form 4 filings following the prior director sale
Key metrics
Price target rationale
Base case ~$22 assumes continued milestone execution but factors in 15-20% further dilution and sector multiple compression — roughly in line with current price. Bull case ~$38 reflects quantum advantage proof-points, successful C-DAC delivery, and short squeeze (near analyst high of $40). Bear case ~$9 reflects a dilutive capital raise, milestone slip, or sector de-rating back toward the 52-week low of $10.30; targets are scenario-weighted given the binary nature of the technology bet rather than multiple-based given negative earnings/FCF.
On Wall Street's view (mixed): The $29.24 mean target implies ~39% upside and reflects optionality on the quantum thesis, which is defensible, but the $15.91-$40 range shows wide disagreement and the fundamentals (-34% revenue, $45M cash, perpetual dilution) don't support the midpoint without a major commercial breakthrough. I lean slightly below the street.
Latest filing (10-K)
Rigetti is a pre-revenue-scale quantum computing company with credible technology progress (99.6% two-qubit fidelity, first multi-chip system) and a landmark Quanta partnership, but it burns cash, dilutes shareholders continuously, and is still years away from the quantum advantage threshold that would unlock mass commercial demand.
Rigetti Computing designs, manufactures, and operates superconducting quantum computers, selling access via cloud services (QCaaS through its proprietary QCS platform and via AWS Braket and Microsoft Azure) and selling physical quantum processing units (QPUs). Revenue currently comes primarily from government and commercial technology development contracts, with a longer-term model oriented toward QPU hardware sales and recurring cloud subscription revenue. The company is vertically integrated, owning Fab-1, its own wafer fabrication facility in Berkeley, CA.
What the news says · bullish
The dominant storyline around RGTI centers on quantum computing momentum, including a 100-qubit processor launch, CHIPS Act funding involvement, and a bullish $40 price target from an analyst, all of which have driven modest post-earnings gains (~3.3%). However, the picture is mixed: the stock slid nearly 10% on the processor launch day despite the positive news, a director sold over 120K shares (a notable insider signal), and valuation risk warnings persist. Bernstein flagging Rigetti as a potential early winner in the quantum race and institutional buying (Clear Street Group) provide some bullish counterweight, but the gap between narrative excitement and fundamental justification remains a key concern.
This analysis is from Jun 15, 2026. Markets move. Get the current read on RGTI and generate fresh AI research on any ticker.
Every call we make is tracked publicly against what the stock actually did. See the track record →
One free AI report every day. No card required.